DaVita
DVA
#2254
Rank
NZ$14.03 B
Marketcap
NZ$196.27
Share price
-0.27%
Change (1 day)
-28.69%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): NZ$17.16

According to DaVita's latest financial reports the company's current EPS (TTM) is NZ$17.05. In 2024 the company made an earnings per share (EPS) of NZ$18.92 an increase over its 2023 EPS that were of NZ$13.05.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$17.16-9.31%
2024NZ$18.9244.94%
2023NZ$13.0527.26%
2022NZ$10.26-35.56%
2021NZ$15.9244.1%
2020NZ$11.0519.7%
2019NZ$9.23540.48%
2018NZ$1.44-76.07%
2017NZ$6.02-19.31%
2016NZ$7.46242.52%
2015NZ$2.18-62.87%
2014NZ$5.8713.43%
2013NZ$5.178.45%
2012NZ$4.77

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Tenet Healthcare
THC
NZ$25.22 47.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
NZ$3.26-80.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Universal Health Services
UHS
NZ$36.63 114.79%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$17.58 3.12%๐Ÿ‡บ๐Ÿ‡ธ USA